Treatment of Intracerebral Hemorrhage-Is the Glass Half Full or Half Empty?

Translational Stroke Research

Volumn 3, Issue SUPPL. 1, 2012, Pages 4-5

  Morgenstern, Lewis B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOT LYSIS; BRAIN EDEMA; BRAIN HEMORRHAGE; EDITORIAL; HEMOSTASIS; HUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; THERAPY EFFECT;

EID: 84862258283     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0179-4     Document Type: Editorial

References (6)

1. Zahuranec DB, Gonzales NR, Brown DL, et al. Presentation of intracerebral haemorrhage in a community. J Neurol Neurosurg Psychiatry. 2006; 77: 340-4.
2. Morgenstern LB, Hemphill 3rd JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010; 41: 2108-29.
3. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008; 358: 2127-37.
4. d'Esterre CD, Chia TL, Jairath A, Lee TY, Symons SP, Aviv RI. Early rate of contrast extravasation in patients with intracerebral hemorrhage. AJNR Am J Neuroradiol. 2011; 32: 1879-84.
5. Selim M, Yeatts S, Goldstein JN, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011; 42: 3067-74.
6. Hemphill 3rd JC, Newman J, Zhao S, Johnston SC. Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke. 2004; 35: 1130-4.